Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3048

Actual shortage: 226 (7%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2799 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CICLESONIDE 50MCG SPRAY, METERED DOSE Resolved 2017-04-11 2018-12-20 6414
APO-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2017-07-17 2017-08-18 15959
APO-BECLOMETHASONE NASAL SPRAY 50MCG SUSPENSION Resolved 2018-03-20 2018-11-22 43501
APO-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2019-01-30 2019-02-01 74022
APO-BECLOMETHASONE NASAL SPRAY 50MCG SUSPENSION Resolved 2020-01-08 2020-03-09 102543
APO-BECLOMETHASONE NASAL SPRAY 50MCG SUSPENSION Resolved 2020-03-27 2020-04-02 109675
APO-BECLOMETHASONE NASAL SPRAY 50MCG SUSPENSION Resolved 2020-09-30 2020-10-13 125332
APO-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2020-10-28 2020-11-02 127367
APO-LATANOPROST 50MCG SOLUTION Resolved 2022-04-01 2022-09-23 157695
APO-BECLOMETHASONE NASAL SPRAY 50MCG SUSPENSION Resolved 2022-04-29 2022-05-27 159695
APO-BECLOMETHASONE NASAL SPRAY 50MCG SUSPENSION Resolved 2022-08-11 2022-09-30 166442
APO-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2022-09-01 2022-09-15 168418
APO-BECLOMETHASONE NASAL SPRAY 50MCG SUSPENSION Resolved 2023-06-02 2023-06-23 193611
APO-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2023-06-29 2024-01-19 196946
APO-BECLOMETHASONE NASAL SPRAY 50MCG SUSPENSION Resolved 2023-07-13 2023-10-15 198473
APO-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2024-01-19 2024-05-22 216669
APO-BECLOMETHASONE NASAL SPRAY 50MCG SUSPENSION Resolved 2024-03-27 2024-04-05 223552
APO TRIAZIDE 50MG 25MG TABLET Resolved 2017-05-16 2017-07-20 10439
APO TRIAZIDE 50MG 25MG TABLET Resolved 2017-11-01 2018-02-17 27770
APO TRIAZIDE 50MG 25MG TABLET Resolved 2020-11-04 2020-12-31 127762

Showing 2401 to 2420 of 3048

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-CETIRIZINE Discontinued 2018-05-31 2018-05-31 50998
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-09-07 2018-09-15 60241
APO-CYCLOSPORINE ORAL SOLUTION Discontinued 2018-09-07 2018-09-15 60408
APO-FAMOTIDINE TAB 20MG USP Discontinued 2018-09-07 2018-09-15 60477
APO-FAMOTIDINE TAB 40MG USP Discontinued 2018-09-07 2018-09-15 60480
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-LATANOPROST-TIMOP Discontinued 2018-09-07 2018-09-15 60572
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-12-21 2018-12-24 70347
APO-TIMOP Discontinued 2019-01-02 2019-01-02 70818
ACID CONTROL Discontinued 2019-01-03 2019-01-03 70906
APO-OFLOXACIN Discontinued 2019-01-03 2019-01-03 71017
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71029

Showing 1 to 20 of 356